A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia

Name: A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
Published: 2009
License: Public Domain

Synta Pharmaceuticals Corp. · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, acute lymphoblastic leukemia, blast-phase chronic myelogenous leukemia, aml, all, cml, synta, sta-9090, ganetespib, hematologic cancers, hsp90 inhibitor, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia

Related documents